Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00HWO
|
||||
Former ID |
DAP001159
|
||||
Drug Name |
Cyclacillin
|
||||
Synonyms |
Aminocyclohexylpenicillin; Bastcillin; Calthor; Ciclacilina; Ciclacillin; Ciclacilline; Ciclacillinum; Ciclacillum; Citosarin; Cyclapen; Noblicil; Orfilina; Peamezin; Syngacillin; Ultracillin; Vastcillin; Vipicil; Wyvital; Aminocyclohexyl penicillin; Cyclacillin [USAN]; AC 98; WY 4508; WY4508; C-12104; Ciclacilina [INN-Spanish]; Ciclacilline [INN-French]; Ciclacillinum [INN-Latin]; Cyclacillin (USAN); Cyclapen (TN); Cyclapen-W; Vastcillin (TN); Wy-4508; Ciclacillin (JP15/INN); Cyclapen-W (TN); (1-Aminocyclohexyl)penicillin; (2S,5R,6R)-6-[(1-aminocyclohexanecarbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-{[(1-aminocyclohexyl)carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(1-aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo-(8CI); 6-(1-Aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid; 6-(1-Aminocyclohexanecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 6-(1-Aminocyclohexanecarboxamido)penicillanic acid; 6-(1-Aminocyclohexylcarboxamido)penicillanic acid; 6beta-(1-aminocyclohexanecarboxamido)-2,2-dimethylpenam-3alpha-carboxylic acid
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Antibiotics
|
||||
Structure |
Download2D MOL |
||||
Formula |
C15H23N3O4S
|
||||
InChI |
InChI=1S/C15H23N3O4S/c1-14(2)9(12(20)21)18-10(19)8(11(18)23-14)17-13(22)15(16)6-4-3-5-7-15/h8-9,11H,3-7,16H2,1-2H3,(H,17,22)(H,20,21)/t8-,9+,11-/m1/s1
|
||||
InChIKey |
HGBLNBBNRORJKI-WCABBAIRSA-N
|
||||
CAS Number |
CAS 3485-14-1
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
396250, 583155, 602914, 7848397, 8139302, 8164183, 11112536, 11446317, 11467148, 11468268, 11486856, 15075673, 29286625, 46508073, 47291276, 47365368, 47440419, 48259416, 48415821, 49699306, 49956857, 50123946, 57269579, 57330251, 74457515, 85788579, 92126086, 103770339, 103914475, 104346698, 124766183, 128055795, 134224408, 134338404, 134985468, 136357160, 137012596, 137178974, 144204085, 160964336, 162516292, 178101519, 179149343, 198937842, 226420447
|
||||
ChEBI ID |
ChEBI:31444
|
||||
Target and Pathway | |||||
Target(s) | DNA | Target Info | Binder | [536284] | |
References | |||||
Ref 468048 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4817). | ||||
Ref 538209 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 062895. | ||||
Ref 551871 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.